Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

TEVA-Losartan Product Recall (2021-05-25)

Canada Type I Ongoing · initiated 2021-05-25

Product safety

DermOtic Oil Ear Drops (2021-05-25)

Canada Type II Ongoing · initiated 2021-05-25

Product safety

SANIS VALSARTAN (2021-05-21)

Canada Type I Ongoing · initiated 2021-05-21

Product safety

SynerClear(2021-05-21)

Canada Type II Ongoing · initiated 2021-05-21

Product safety

Elemental Nutrition(2021-05-21)

Canada Type II Ongoing · initiated 2021-05-21

Product safety

Natural Concepts Sanitizing Gel(2021-05-12)

Canada Type II Ongoing · initiated 2021-05-12

COVID

Magnesium Bisglycinate Powder 250 - Berry Hibiscus (2021-05-06)

Canada Type II Ongoing · initiated 2021-05-06

Product safety

Magnesium Bisglycinate Powder 250- Rose Hip Dragonfruit (2021-05-06)

Canada Type II Ongoing · initiated 2021-05-06

Product safety

APO-AMITRIPTYLINE 10mg (2021-04-29)

Canada Type I Ongoing · initiated 2021-04-29

Product safety

Bio-Odeur(2021-04-29)

Canada Type II Ongoing · initiated 2021-04-29

COVID

Ephedrine HCL (2021-04-26)

Canada Type III Ongoing · initiated 2021-04-26

Product safety

Vitafusion Fibre Well(2021-04-19)

Canada Type I Ongoing · initiated 2021-04-19

Product safety

L'iIl Critters Gummy Vites Complete Multivitamins(2021-04-19)

Canada Type I Ongoing · initiated 2021-04-19

Product safety

Vitafusion MultiVites(2021-04-19)

Canada Type I Ongoing · initiated 2021-04-19

Product safety

AlumierMD Renew 30 Pro(2021-04-19)

Canada Type II Ongoing · initiated 2021-04-19

Product safety

KeraSpa(2021-04-19)

Canada Type II Ongoing · initiated 2021-04-19

COVID

Umbrell(2021-04-16)

Canada Type II Ongoing · initiated 2021-04-16

COVID

APO-AMITRIPTYLINE 10mg (2021-04-13)

Canada Type I Ongoing · initiated 2021-04-13

Product safety

Orfenace Tablet 100mg(2021-04-13)

Canada Type I Ongoing · initiated 2021-04-13

Product safety

Teva-Varenicline 0.5mg (2021-04-06)

Canada Type II Ongoing · initiated 2021-04-06

Product safety

Teva-Varenicline 1mg (2021-04-06)

Canada Type II Ongoing · initiated 2021-04-06

Product safety

Teva-Varenicline (2021-04-06)

Canada Type II Ongoing · initiated 2021-04-06

Product safety

Ibuprofen Extra Strength Caplets 400mg (2021-04-06)

Canada Type III Ongoing · initiated 2021-04-06

Product safety

Ibuprofen Caplets 200mg(2021-04-06)

Canada Type III Ongoing · initiated 2021-04-06

Product safety

Ibuprofen 200mg(2021-04-06)

Canada Type III Ongoing · initiated 2021-04-06

Product safety